NTRA News and Press, Natera Inc. From 06/02/24

2024-06-02 23:01:06 ET Summary Duquesne Family Office's 13F portfolio value increased from $3.35B to $4.39B in Q1 2024. The largest five stakes in the portfolio are Microsoft, Coupang, Teck Resources, Vistra Corp., and Natera, Inc. Stanley Druckenmiller's family office made ne...

Includes new results from the ProActive study, reinforcing the utility of the Prospera™ Kidney test for ongoing surveillance of transplant rejection Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that the company wil...

2024-05-26 10:15:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera’s management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET). A live webcast ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the company, along with its collaborators, will present new data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 – June 4, 2024. The pre...

2024-05-15 16:27:14 ET Read the full article on Seeking Alpha For further details see: Duquesne Family Office top Q1 buys, cuts: Coherent, Eli Lilly, others

2024-05-13 08:30:06 ET BTIG analyst issues BUY recommendation for NTRA on May 13, 2024 07:22AM ET. The previous analyst recommendation was Buy. NTRA was trading at $105.29 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst re...

A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 98.7% to $8.88 on volume of 168,692,127 shares AEye Inc. (LIDR) rose 115.0% to $2.58 on volume of 156,236,079 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 17.3% to $0.7609 on volume of 123,678,040 s...

A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 128.7% to $10.225 on volume of 69,182,168 shares SoundHound AI Inc. (SOUN) rose 23.9% to $5.885 on volume of 25,153,154 shares Greenwave Technology Solutions Inc. (GWAV) fell 31.9% to $0.0476 on volume of 22,3...

2024-05-10 08:00:05 ET Catherine Ramsey Schulte from Robert W. Baird issued a price target of $117.00 for NTRA on 2024-05-10 06:50:00. The adjusted price target was set to $117.00. At the time of the announcement, NTRA was trading at $95.55. The overall price target cons...